HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salbutamol plus beclomethasone dipropionate (Ventolin Flogo) vs. fenoterol (Dosberotec) in chronic obstructive lung disease therapeutic strategy: a 4-week clinical trial.

Abstract
Thirty patients suffering from acute exacerbations of chronic obstructive lung disease were divided on a random basis into two groups and allocated, for purposes of comparison, to treatment either with a combination of salbutamol plus beclomethasone dipropionate or with fenoterol. The two treatments being compared were evaluated on the basis of ventilatory function parameters (FEV1, FVC), bronchodilatation tests and subjective and objective clinical investigations regarding the bronchopulmonary picture and the tolerance of the drugs. All investigations and tests were performed according to identical procedures both before and after 4 weeks' treatment, and the data obtained evaluated by statistical analysis. The results proved positive for both preparations, though the combination of salbutamol plus beclomethasone dipropionate produced a greater bronchodilator effect, facilitated a more sensitive response to the bronchodilator on the part of bronchial beta2-adrenergic receptors, and was characterized by better tolerance.
AuthorsG Perri, M Giovannini, E Spada
JournalInternational journal of clinical pharmacology, therapy, and toxicology (Int J Clin Pharmacol Ther Toxicol) Vol. 23 Issue 5 Pg. 274-8 (May 1985) ISSN: 0174-4879 [Print] Germany
PMID3891642 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Drug Combinations
  • Ethanolamines
  • albuterol, beclomethasone drug combinations
  • Fenoterol
  • Beclomethasone
  • Albuterol
Topics
  • Aged
  • Albuterol (administration & dosage, therapeutic use)
  • Beclomethasone (administration & dosage, therapeutic use)
  • Clinical Trials as Topic
  • Drug Combinations (therapeutic use)
  • Ethanolamines (administration & dosage)
  • Fenoterol (administration & dosage)
  • Forced Expiratory Volume
  • Humans
  • Lung Diseases, Obstructive (drug therapy)
  • Middle Aged
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: